Skip to main content
ABINGDON HEALTH PLC logo

ABINGDON HEALTH PLC — Investor Relations & Filings

Ticker · ABDX ISIN · GB00BLF79J41 LEI · 213800XFI4WV3FBILO20 IL Manufacturing
Open in API
Filings indexed 261 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country GB United Kingdom
Listing IL ABDX

About ABINGDON HEALTH PLC

https://www.abingdonhealth.com/

Abingdon Health PLC is a contract development and manufacturing organization (CDMO) that specializes in lateral flow assays, also known as rapid tests. The company provides a comprehensive, fully integrated service to a global customer base, supporting diagnostic projects from initial concept and development through to high-volume automated manufacturing and regulatory support. Its services cater to a wide range of sectors, including clinical, animal health, environmental, and plant health. Abingdon Health also develops and manufactures lateral flow readers and smartphone reader applications, which complement its assay services by enabling digital data capture and analysis.

Recent filings

Filing Released Lang Actions
Presentation at Mello2026
Regulatory Filings Classification · 80% confidence The document is an RNS press release announcing that Abingdon Health executives will present at the Mello2026 investor event. There is no attached financial report, presentation slides, or substantive financial data—just an event announcement. This falls under general regulatory announcements and does not match any specific category, so it is classified as a Regulatory Filing (RNS).
2026-05-29 English
US tax credit agreement
Regulatory Filings Classification · 85% confidence The document is an RNS announcement from Abingdon Health PLC regarding a US Business Development Tax Credit Agreement. It does not contain financial statements, results, or formal report content; rather it is a corporate news release of a government tax credit arrangement. This does not fit specialized categories like capital raising (CAP) or earnings (ER), so it falls under general regulatory/regulatory news announcements.
2026-05-27 English
Earn-out Consideration and Issue of Equity
Share Issue/Capital Change Classification · 85% confidence The document is an RNS announcement detailing the satisfaction of earn‐out conditions for an acquisition and the subsequent issue of 1,673,640 new ordinary shares, including details on admission to trading and total voting rights. This is a notification of a share issue/capital change, fitting the Share Issue/Capital Change category (SHA).
2026-05-19 English
Launch of LVOne Stroke Test by UpFront Diagnostics
Regulatory Filings Classification · 92% confidence The document is a press release disseminated via RNS detailing a product launch (UK launch of LVOne Stroke Triage Test) and company partnership activities. It does not contain financial statements, voting results, management changes, dividends, or other structured report content. It is not announcing the publication of a formal report (Menu vs Meal rule). This fits the fallback category for general regulatory announcements through RNS.
2026-05-11 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a TR-1 form notification of major holdings, which is a regulatory filing used to notify changes in significant share ownership levels. It includes details such as the identity of the issuer, the shareholder, the percentage of voting rights held, and the date the threshold was crossed. The document is not a financial report, earnings release, or any other type of report but a formal notification of shareholding changes. This matches the definition of Major Shareholding Notification (MRQ). The document length is 8457 characters, which is sufficient to contain detailed information, confirming it is the notification itself, not just an announcement of a report.
2026-05-07 English
Update on Partnership with 4TEEN4 Pharmaceuticals
Regulatory Filings Classification · 95% confidence The document is an update announcement from Abingdon Health plc regarding its partnership with 4TEEN4 Pharmaceuticals. It provides details about the collaboration, technical capabilities, and comments from company executives. There are no financial statements, regulatory certifications, voting results, or management changes reported. The document is a corporate news update about a partnership and project progress, not a financial report, regulatory filing, or meeting material. It is a typical Regulatory Filing (RNS) as it provides a general corporate update without fitting into more specific categories like earnings release, annual report, or capital update.
2026-05-06 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.